Dionex is pleased to announce the release of the MAbPac^TM SCX-10 column, designed specifically for high-resolution analysis and characterization of monoclonal antibody variants. This new column's unique nonporous pellicular resin provides exceptionally high resolving power, permitting the separation of monoclonal antibody variants that differ by as little as one charged residue. Hydrophobic interactions with the resin are essentially eliminated for very efficient peaks. The MAbPac SCX-10 column is designed to address the regulatory requirements for biopharmaceutical characterization, providing the unmatched columnto-column and lot-to-lot reproducibility you expect from the leader in monoclonal antibody analysis solutions.

The MAbPac SCX-10 strong-cation-exchange column is complimentary to the industry-leading Dionex ProPac® WCX-10 column for monoclonal antibody variant analysis, offering an alternative selectivity and providing higher resolution for variant analysis of most monoclonal antibody samples than the ProPac WCX-10 column. The new MAbPac SCX-10 column is available in a 4 × 250 mm format.

For details on this and other ultrahigh efficiency and high-resolution columns, visit www.dionex.com.

Dionex (NASDAQ:DNEX) is a global leader in the manufacturing and marketing of liquid chromatography and sample preparation systems, consumables, and software for chemical analysis. The company's systems are used worldwide in environmental analysis and by the life sciences, chemical, petrochemical, food and beverage, power generation, and electronics industries. Our expertise in applications and instrumentation helps analytical scientists to evaluate and develop pharmaceuticals, establish environmental regulations, and produce better industrial products.

MAbPac is a trademark and ProPac is a registered trademark of Dionex Corporation.